Bernstein reiterates Outperform on Zydus Lifesciences, targets ₹1,457
Zydus Lifesciences shares rose nearly 3% on Sept. 18 after Bernstein maintained an "Outperform" rating and set a target price of ₹1,457.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.